| Dec'17 | Dec'16 | |||||
|---|---|---|---|---|---|---|
Revenue (note 8) | ||||||
Licensing revenue | ||||||
418 | 118 | |||||
Research and development revenue | ||||||
0 | 50 | |||||
Contract services | ||||||
2 | 5 | |||||
Revenue | ||||||
420 | 173 | |||||
Expenses | ||||||
Research and development (note 12) | ||||||
33,930 | 14,534 | |||||
Corporate, administration and business development (note 12) | ||||||
12,096 | 6,970 | |||||
Amortization of acquired intellectual property and other intangible assets (note 6) | ||||||
1,434 | 1,457 | |||||
Amortization of property and equipment | ||||||
22 | 22 | |||||
Contract services | ||||||
1 | 4 | |||||
Other expense (income) (note 13) | ||||||
195 | -2,213 | |||||
Expenses, by nature | ||||||
47,288 | 25,200 | |||||
Net loss before change in estimated fair value of derivative warrant liabilities | ||||||
-46,868 | -25,027 | |||||
Change in estimated fair value of derivative warrant liabilities (note 10) | ||||||
-23,924 | 1,732 | |||||
Net loss for the year | ||||||
-70,792 | -23,295 | |||||
Net change in fair value of short term investments (note 4) | ||||||
-78 | 0 | |||||
Net comprehensive loss for the year | ||||||
-70,870 | -23,295 | |||||
Basic and diluted loss per common share (in dollars per share) | ||||||
-0.92 | -0.66 | |||||